Patents by Inventor Hirokazu Takahashi

Hirokazu Takahashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170229809
    Abstract: The present invention provides a connector includes a housing having a fitting opening for the object to be connected, signal contacts retained in the housing in parallel disposition, a pressure member capable of pressing the signal contacts, and power source contacts. The power source contacts are retained besides the signal contacts, have a thickness dimension larger than that of the signal contacts and are to be pressed by the pressure member together with the signal contacts. The power source contacts include a power source contact with a fixation function, having not only the power source connection function but also a function of temporally fixing the object to be connected at a correct insertion position with respect to the signal contacts as well as a function of clamping and fixing the object to be connected in a state of being pressed by the pressure member.
    Type: Application
    Filed: February 10, 2017
    Publication date: August 10, 2017
    Inventors: Harunori URAI, Masayuki SUZUKI, Hirokazu TAKAHASHI, Yuuki NAKANO
  • Patent number: 9695206
    Abstract: This invention provides compounds, compositions and methods for modulating the expression of human p21 using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. Provided are a range of siRNA structures, having one or more nucleotides being modified or chemically-modified. Advantageous structures include siRNAs with 2?-deoxy nucleotides located in the seed region, as well as other nucleotide modifications.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: July 4, 2017
    Assignee: Nitto Denko Corporation
    Inventors: Kenjirou Minomi, Jens Harborth, Cima Cina, Kwok Yin Tsang, Wenbin Ying, Hirokazu Takahashi
  • Patent number: 9650961
    Abstract: A gas turbine combustor includes: multiple gaseous fuel nozzles to inject gaseous fuel; a manifold to distribute gaseous fuel to the multiple gaseous fuel nozzles; a burner flange to secure a burner to an end cover; and a burner body to connect the manifold and the burner flange. Gaseous fuel passages are provided in the end cover, the burner flange, and the burner body. The gaseous fuel passage communicates with the manifold. A second manifold is provided in the burner flange. The gaseous fuel passage is provided in the burner body to make the second manifold communicate with the first mentioned manifold.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: May 16, 2017
    Assignee: Mitsubishi Hitachi Power Systems, Ltd.
    Inventors: Yoshitaka Hirata, Akinori Hayashi, Hirokazu Takahashi, Toshifumi Sasao, Shohei Yoshida
  • Publication number: 20170043604
    Abstract: A front face side substrate provided between a supporting member and a receiving layer of a thermal transfer image-receiving sheet. The front face side substrate includes a front face side layer provided on one surface of a substrate layer and a rear face side layer provided on another surface of the substrate layer. The substrate layer includes (A) a propylene-based polymer, (B) calcium carbonate, and (C) titanium oxide, and the weight of (A) is 70% by weight to 94.5% by weight, the weight of (B) is 5% by weight to 28% by weight, and the weight of (C) is 0.5% by weight to 3% by weight, based on the assumption that the total weight of (A), (B) and (C) is 100% by weight. The front face side layer includes a modified propylene-based polymer, and the rear face side layer includes a propylene-based polymer.
    Type: Application
    Filed: December 9, 2014
    Publication date: February 16, 2017
    Applicants: Dai Nippon Printing Co., Ltd., Mitsui Chemicals Tohcello, Inc.
    Inventors: Hirokazu TAKAHASHI, Junpei OOMURA, Hiroshi MATSUURA, Hiroshi HONDA
  • Publication number: 20170022500
    Abstract: Provided are: a targeting molecule targeting a target cell which is selected from the group consisting of a stellate cell, a myofibroblast, a cancer-associated fibroblast, a tumor cell and a cell expressing STRA6, said targeting molecule being selected from the group consisting of (1) a peptide containing an amino acid sequence in the cell-binding region of RBP, (2) a variant peptide of the aforesaid peptide (1), said variant peptide having a comparable targetability to peptide (1), and (3) a peptide mimetic having a comparable targetability to peptide (1) or peptide (2); a targeting agent, a carrier, a complex and a medicinal composition each comprising the targeting molecule; a method for treating, examining, diagnosing or monitoring a disease related to the aforesaid target cell; a method for labeling, detecting or imaging the target cell, etc.
    Type: Application
    Filed: April 1, 2015
    Publication date: January 26, 2017
    Inventors: Kenjiro Minomi, Hirokazu Takahashi, Erika Terada, Yoshiro Niitsu
  • Patent number: 9554005
    Abstract: An information processing apparatus includes a reception unit and a display controller. The reception unit receives an operation for selecting a destination from a transmission destination list containing a registered mail address of the destination to which an image is to be transmitted. The display controller displays an object image in a predetermined display region. The object image indicates a parameter of an image reading unit that reads the image. When the destination is selected by the operation, the display controller makes the display region display the mail address registered in the transmission destination list in place of the object image. When a preset time period elapses, the display controller sets the display back to the object image.
    Type: Grant
    Filed: October 22, 2013
    Date of Patent: January 24, 2017
    Assignee: FUJI XEROX CO., LTD.
    Inventor: Hirokazu Takahashi
  • Publication number: 20160377294
    Abstract: A fuel nozzle for gas turbine combustor of the present invention includes a diffusion combustion burner including a diffusion fuel nozzle, a premixing combustion burner including a premixing fuel nozzle, an end flange to which the diffusion combustion burner and the premixing combustion burner are mechanically joined, and a diffusion combustion burner support which fixes the diffusion combustion burner to the end flange and is mounted around the premixing fuel nozzle in a manner to cover a root portion of the premixing fuel nozzle, the root portion being a junction between the premixing fuel nozzle and the end flange. An outside diameter of the premixing fuel nozzle longitudinally varies in a manner to progressively increase toward the junction. A maximum diameter of the root portion of the premixing fuel nozzle is greater than an inside diameter of a hole formed in the diffusion combustion burner support.
    Type: Application
    Filed: June 21, 2016
    Publication date: December 29, 2016
    Inventors: Yoshihide WADAYAMA, Satoshi KUMAGAI, Yasuhiro WADA, Hirokazu TAKAHASHI
  • Publication number: 20160281083
    Abstract: Provided herein are compositions, methods and kits for modulating expression of target genes, particularly of tissue inhibitor of metalloproteinase 1 and of tissue inhibitor of metalloproteinase 2 (TIMP1 and TIMP2, respectively). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA) or short hairpin RNA (shRNA)) that modulate a gene encoding TIMP1 and TIMP2, for example, the gene encoding human TIMP1 and TIMP2. The composition and methods disclosed herein may also be used in treating conditions and disorders associated with TIMP1 and TIMP2 including fibrotic diseases and disorders including liver fibrosis, pulmonary fibrosis, peritoneal fibrosis and kidney fibrosis.
    Type: Application
    Filed: October 30, 2015
    Publication date: September 29, 2016
    Applicant: NITTO DENKO CORPORATION
    Inventors: Yoshiro NIITSU, Hirokazu TAKAHASHI, Yasunobu TANAKA, Elena FEINSTEIN, Sharon AVKIN-NACHUM, Hagar KALINSKI, Igor METT
  • Publication number: 20160208265
    Abstract: This invention provides compounds, compositions and methods for modulating the expression of human GST-? using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. Provided are a range of siRNA structures, having one or more of nucleotides being modified or chemically-modified. Advantageous structures include siRNAs with 2?-deoxy nucleotides located in the seed region, as well as other nucleotide modifications.
    Type: Application
    Filed: December 28, 2015
    Publication date: July 21, 2016
    Inventors: Yoshiro Niitsu, Kenjirou Minomi, Hirokazu Takahashi, Erika Terada, Jens Harborth, Cima Cina, Jun Zhang, Mohammad Ahmadian, Wenbin Ying
  • Publication number: 20160208256
    Abstract: This invention provides compounds, compositions and methods for modulating the expression of human p21 using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. Provided are a range of siRNA structures, having one or more nucleotides being modified or chemically-modified. Advantageous structures include siRNAs with 2?-deoxy nucleotides located in the seed region, as well as other nucleotide modifications.
    Type: Application
    Filed: December 28, 2015
    Publication date: July 21, 2016
    Inventors: Yoshiro Niitsu, Kenjirou Minomi, Jens Harborth, Cima Cina, Kwok Yin Tsang, Wenbin Ying, Hirokazu Takahashi
  • Publication number: 20160208254
    Abstract: This invention provides compounds, compositions and methods for modulating the expression of human GST-? using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. A nucleic acid molecule can have a) a polynucleotide sense strand and a polynucleotide antisense strand; b) each strand of the molecule being from 15 to 30 nucleotides in length; c) a contiguous region of from 15 to 30 nucleotides of the antisense strand being complementary to a sequence of an mRNA encoding GST-?; and d) at least a portion of the sense strand can be complementary to at least a portion of the antisense strand, and the molecule has a duplex region of from 15 to 30 nucleotides in length.
    Type: Application
    Filed: December 28, 2015
    Publication date: July 21, 2016
    Inventors: Yoshiro Niitsu, Kenjirou Minomi, Hirokazu Takahashi, Erika Terada, Jens Harborth, Cima Cina, Jun Zhang, Mohammad Ahmadian, Wenbin Ying
  • Publication number: 20160208255
    Abstract: This invention provides compounds, compositions and methods for modulating the expression of human p21 using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. A nucleic acid molecule can have a) a polynucleotide sense strand and a polynucleotide antisense strand; b) each strand of the molecule being from 15 to 30 nucleotides in length; c) a contiguous region of from 15 to 30 nucleotides of the antisense strand being complementary to a sequence of an mRNA encoding p21; and d) at least a portion of the sense strand can be complementary to at least a portion of the antisense strand, and the molecule has a duplex region of from 15 to 30 nucleotides in length.
    Type: Application
    Filed: December 28, 2015
    Publication date: July 21, 2016
    Inventors: Yoshiro Niitsu, Kenjirou Minomi, Jens Harborth, Cima Cina, Kwok Yin Tsang, Wenbin Ying, Hirokazu Takahashi
  • Patent number: 9377192
    Abstract: A highly-reliable combustor is provided that allows flash back of flame into a premixer to be suppressed. The combustor has a mixing chamber forming member 110 that forms a mixing chamber thereinside. The mixing chamber includes a first mixing chamber 200 broadening toward a downstream side. The member 110 includes air introduction holes 202, 203, 204 formed in a plurality of rows in an axial direction, with the air introduction holes being arranged plurally in a circumferential direction of the mixing chamber. The member 110 includes a fuel ejection hole 206 provided in a wall surface which forms the air introduction hole. The air introduction holes 202, 203, 204 are circumferentially eccentrically installed. The air introduction holes 202 located in the most upstream row are more inclined toward the downstream side than the air introduction holes 203, 204 located in the rows other than the most upstream row.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: June 28, 2016
    Assignee: Mitsubishi Hitachi Power Systems, Ltd.
    Inventors: Yoshitaka Hirata, Shohei Yoshida, Tatsuya Sekiguchi, Akinori Hayashi, Hirokazu Takahashi
  • Publication number: 20160122178
    Abstract: A driving apparatus (101) is provided with: a first base part (110); a second base part (120); an elastic part (210) configured to couple the first base part with the second base part; and a driven part (400) supported by the second base part in a drivable aspect. According to such a driving apparatus, for example, if a driving force is applied to the first base part, the driving force is transmitted to the second base part via the elastic part. Thus, the driven part supported by the second base part can be preferably driven.
    Type: Application
    Filed: December 19, 2013
    Publication date: May 5, 2016
    Inventors: Kenjiro FUJIMOTO, Hirokazu TAKAHASHI, Yuuichi YAMAMURA, Mitsuru KOARAI, Tomotaka YABE, Yuji FUKASAWA
  • Publication number: 20160108399
    Abstract: Provided herein are compositions, methods and kits for modulating expression of target genes, particularly heat shock protein 47 (hsp47). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA) or short hairpin RNA (shRNA)) that modulate a gene encoding hsp47, for example, the gene encoding human hsp47. The composition and methods disclosed herein may also be used in treating conditions and disorders associated with hsp47 such as liver fibrosis, pulmonary fibrosis, peritoneal fibrosis and kidney fibrosis.
    Type: Application
    Filed: October 27, 2015
    Publication date: April 21, 2016
    Applicant: NITTO DENKO CORPORATION
    Inventors: Xiaomei JIN, Lei YU, Hirokazu TAKAHASHI, Yasunobu TANAKA, Yoshiro NIITSU, Elena FEINSTEIN, Sharon AVKIN-NACHUM, Hagar KALINSKI, Igor METT, Shai ERLICH, Elizabeth C. SQUIERS, Ning CHEN
  • Patent number: 9256439
    Abstract: A data processing apparatus causes multiple processors to process in parallel input data that is arrayed two-dimensionally, and stores the data of the processing results in a cache line of a cache memory, where the data of the processing results includes a plurality of pieces of data of a predetermined width that is smaller than a cache line width of the cache memory. The data stored in the cache memory is then transferred together to a main memory as in the cache line.
    Type: Grant
    Filed: April 10, 2012
    Date of Patent: February 9, 2016
    Assignee: Canon Kabushiki Kaisha
    Inventor: Hirokazu Takahashi
  • Publication number: 20160025346
    Abstract: A combustor is capable of ignition and flame propagation at low fuel concentrations for gas or liquid fuel. Combustors are disposed annularly along an outer peripheral portion of a casing of a turbine. A combustion chamber burns fuel and air to generate a combustion gas. A diffusion burner is disposed upstream of the combustion chamber; and a plurality of premix burners are disposed around the diffusion burner. Cross fire tubes provide communication between combustion chambers of combustors adjacent to each other. A cross fire tube connected to a combustor adjacent to a first side in the circumferential direction of the casing is disposed so as to have a central axis passing over a premix burner as viewed from the combustion chamber and another cross fire tube connected to the combustor adjacent to a second side is disposed so as to have a central axis passing between two premix burners.
    Type: Application
    Filed: July 23, 2015
    Publication date: January 28, 2016
    Inventors: Yoshitaka HIRATA, Tatsuya SEKIGUCHI, Tomoki URUNO, Akinori HAYASHI, Hirokazu TAKAHASHI
  • Patent number: 9230716
    Abstract: A coaxial cable includes a central conductor, a fluororesin insulation, and outer conductor and a jacket covering the outer conductor. The central conductor has three single element twisted wires. The central conductor has an outer diameter and the three single element twisted wires having a predetermined twist pitch. The fluororesin insulation covers the central conductor such that all of the twisted single element wires of the central conductor contact the fluororesin insulation. The fluororesin insulation is a non-foam insulation material. A series of voids are defined between portions of the central conductor and an inner surface of the fluororesin insulation. The outer conductor is disposed on the external periphery of the insulation. The adhesive force between the central conductor and the insulation, and a breaking strength of the central conductor have the following relationship: adhesive force?? breaking strength.
    Type: Grant
    Filed: December 9, 2014
    Date of Patent: January 5, 2016
    Assignee: SUMITOMO ELECTRIC INDUSTRIES, LTD.
    Inventors: Tatsunori Hayashishita, Hirokazu Takahashi
  • Patent number: 9206424
    Abstract: Provided herein are compositions, methods and kits for modulating expression of target genes, particularly heat shock protein 47 (hsp47). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA) or short hairpin RNA (shRNA)) that modulate a gene encoding hsp47, for example, the gene encoding human hsp47. The composition and methods disclosed herein may also be used in treating conditions and disorders associated with hsp47 such as liver fibrosis, pulmonary fibrosis, peritoneal fibrosis and kidney fibrosis.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: December 8, 2015
    Assignee: NITTO DENKO CORPORATION
    Inventors: Xiaomei Jin, Lei Yu, Hirokazu Takahashi, Yasunobu Tanaka, Yoshiro Niitsu, Elena Feinstein, Sharon Avkin-Nachum, Hagar Kalinski, Igor Mett, Shai Erlich, Elizabeth C Squiers, Ning Chen
  • Patent number: 9198946
    Abstract: A process for selectively removing caffeine from a caffeine-containing catechin composition, which includes dissolving the caffeine-containing catechin composition in a 9/1 to 1/9 by weight mixed solution of an organic solvent and water, and then bringing the resultant solution into contact with activated carbon alone or with activated carbon and also acid clay or activated clay; and a packaged beverage containing such a decaffeinated composition.
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: December 1, 2015
    Assignee: KAO CORPORATION
    Inventors: Yoshikazu Ogura, Susumu Ohishi, Masahiro Fukuda, Hirokazu Takahashi, Eri Itaya, Atsushi Konishi